Allworth Financial LP Sonoma Pharmaceuticals, Inc. Transaction History
Allworth Financial LP
- $14 Billion
- Q1 2024
A detailed history of Allworth Financial LP transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 65 shares of SNOA stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 65
-0.0%
Holding current value
$13
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SNOA
# of Institutions
17Shares Held
164KCall Options Held
0Put Options Held
0-
Susquehanna International Group, LLP Bala Cynwyd, PA46.1KShares$9,6700.0% of portfolio
-
Geode Capital Management, LLC Boston, MA35.8KShares$7,5130.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$5,1060.0% of portfolio
-
Xtx Topco LTD London, X016.5KShares$3,4570.0% of portfolio
-
Two Sigma Securities, LLC New York, NY13.5KShares$2,8290.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $651K
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...